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Abstract  
Aim: The aim of this paper is to explore patients’ accounts of screening and being managed 
for colonisation with the antimicrobial resistant organism, Carbapenemase-producing 
Enterobacteriaceae (CPE), when in hospital.  
Background:    Antimicrobial resistance (AMR) has been identified as one of the biggest 
global health challenges of the 21st Century. As the threat from AMR grows, screening to 
identify patients who are colonised with resistant organisms such as CPE, is becoming an 
increasingly important aspect of nursing practice, in order to reduce risk of transmission of 
infection within hospitals. There is currently little research evidence on the patient 
experience of hospital management of CPE colonisation.  
Methods: Qualitative semi-structured telephone interviews were undertaken, using a topic 
guide. Nine patients participated in the study.  The data was analysed thematically and 
rigour maintained through peer review.  The COREQ checklist was used.   
Results: Two main themes were identified: ‘I can’t make sense of CPE’, illustrating 
limitations in patients’ understandings of CPE; and, ‘I feel as if they are saying it is my fault’, 
indicating the feelings of responsibility and blame which patients experienced.  
Conclusions: This paper contributes original evidence to the limited literature on patients’ 
experiences of being colonised with CPE.  The findings suggest that support and information 
provided for patients, by healthcare professionals needs to be based on current evidence-
based guidance on the nature of CPE and its implications for patient care, as well as being 
responsive to patients’ emotional needs.    
Relevance to clinical practice:  This study has international relevance for nursing practice. 
As the global threat of AMR grows, the demands on health care providers to manage 
resistant organisms and their implications for patient care within health care settings is 
increasing.   Enabling health care professionals to engage sensitively with patients being 
managed for colonisation with CPE is paramount to providing patient-centred care.    
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Impact statement 
What does this paper contribute to the wider global clinical community? 
 In a bid to manage the consequences of AMR for patient care, screening for resistant 
organisms is an increasingly important aspect of clinical practice, both within the UK 
and worldwide. 
 This paper builds on existing knowledge about patient experience of HAIs and makes 
a unique contribution in relation to understanding patients’ experiences of, and 
emotional responses to, being managed for colonisation with CPE.  
 Learning from patients’ accounts of their experiences of CPE screening, clinicians will 
be able to tailor their interactions with patients appropriately to provide effective, 
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Introduction  
Antimicrobial resistance (AMR) has been named as one of the top global health challenges 
of 2019 by the World Health Organisation (World Health Organisation 2019).  As the global 
threat from AMR grows, screening for antimicrobial resistant organisms (AMROs) is 
becoming an increasingly important aspect of clinical practice, worldwide. The spread and 
presence of Carbapenemase-producing Enterobacteriaceae (CPE) is of particular concern 
within health care settings and for patients; limited treatment options are available for 
infections caused by this organism and the impact on patient outcomes and the economic 
resources required for patient care and to manage CPE are significant (Poole, George et al. 
2016).  
Background 
A recent systematic review of patient experience of health-care associated infections 
highlighted a small but growing literature on patients’ experiences of specific HAIs (Authors, 
2018); however, no included studies discussed CPE, which is an emerging organism of 
concern.  In relation to other HAIs, the review highlighted that patients experience a range 
of physical and emotional responses to HAI and that the extent and nature of these 
responses varies by the AMRO.   The systematic review also emphasises the substantive 
emotional and physical burden of HAIs for patients both while in hospital and after their 
hospital discharge.   Overall, the review findings indicate that the cultural context of HAIs is 
complex and changing as our knowledge of different AMROs and their implications for 
patients’ health care experiences develops as new understandings emerge.  
CPE is a relatively new AMRO with guidance for its management being published within the 
last 5 years (Public Health England 2014, Center for Disease Control 2015, Health Protection 
Scotland 2016).  Recent research suggests that at a general public level, CPE screening is 
acceptable due to the potential individual and collective benefits being greater than any 
discomfort caused by the screening test or personal disadvantages (Authors, 2018).  
Studies to date suggest broadly, methicillin-resistant Staphylococcus aureus (MRSA) has 
taken the dominant spot as the cultural reference for HAIs among the general public, 
including patients, their friends and families (Andersson, Lindholm et al. 2011).  
Final Author Approved Version: King, C, Grandison, T, Cawthorne, J, Currie, K  
Patient experience of hospital screening for carbapenemase-producing Enterobacteriaceae 
(CPE): a qualitative study 
4 
Commentary and analysis of why this is proposes that it is because MRSA was linked 
politically within the mainstream media with a number of agendas including the cleanliness 
of hospitals and the state of the NHS (Crawford, Brown et al. 2008, Koteyko, Nerlich et al. 
2008).   
As such, with every new and emerging AMRO it is important to note that it is responded to 
by neither health care professionals nor patients with a clean slate.  Their views of emerging 
organisms build on their experiences of other AMROs and also draw on wider references 
gleaned from the media and other sources, which are often politically infused.   As such, 
although AMROs are a health care problem, it is important to think of and analyse it within 
the wider social, cultural and political frames which are shaping patients’ experiences.  
CPE screening commonly involves a Clinical Risk Assessment and for those identified as 
being at risk, a rectal swab. In the NHS Trust where the research was undertaken the policy 
was to screen all ‘high risk’ patients (in accordance with the Public Health England toolkit), 
on admission.  In addition, all in-patients in clinical areas identified as having a high rate of 
CPE acquisition amongst their patients were screened once weekly, in order to identify any 
cross-transmission.  From 2009-2016, the Trust policy was to isolate all patients who had 
been screened as positive for CPE.   From 2016, a risk based approach to screening was 
adopted.   
The aim of the research reported here was to explore patients’ accounts of being screened 
for and subsequently managed for colonisation with the antimicrobial resistant organism 
CPE during a hospital admission. 
Methods 
Study design  
The study was part of a wider mixed methods project focused on patient experience and the 
acceptability of screening for carbapenemase-producing Enterobacteriaceae (CPE) (Authors, 
2018).   Pope and May (1999) highlight the usefulness of qualitative methods in exploring 
patients’ experience of health care. The use of qualitative methods in health services 
research has since been widely endorsed by those working in the field (Greenhalgh, 
Annandale et al. 2016).  As such, it was decided that qualitative methods would provide the 
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means to generate an in-depth understanding of patient experience in relation to CPE.  
Reporting of the study was guided by the COREQ checklist (Tong, Sainsbury et al. 2007) (See 
Supplementary File 1).  
Ethical approval  
The study received ethical approval through the Integrated Research Application System 
(IRAS number (anonymised). In addition, the study was approved by the Health Research 
Authority and a Capacity and Capability Assessment was carried out and approved by the 
Research and Development Office of the NHS Foundation Trust involved, which then 
granted a Letter of Access. The full study was reviewed and approved by the (anonymised) 
at (anonymised). All of the patients were provided with written information about the 
study.  All of the patients who agreed to take part in the study signed written consent forms.    
Recruitment 
Participants were recruited from an English NHS foundation trust hospital that had 
experienced its first outbreak of CPE in 2009 and had managed several outbreaks since.   
Adult patients who were hospitalised between January 2016 and December 2017 and found 
to be colonised with CPE during routine screening, and who were consequently managed for 
CPE within hospital, were eligible for study participation.   
A number of postal and face-to-face recruitment strategies were used to engage with 
patients, with varying effectiveness.  Two patients were recruited after information was 
posted to all of the patients on the hospital database (approximately 150) who had been 
screened for CPE and received a positive swab result over an 11month period. The majority 
of patients (7 patients) were recruited by a nurse consultant who was enrolled to identify 
patients who had received a positive CPE test result, to provide face-to-face information and 
consent patients to the study while they were still admitted to hospital.   
Data collection 
Semi-structured telephone interviews of participants post hospital discharge were 
conducted by an experienced PhD qualified academic researcher not involved in clinical care 
(Author 1).  A topic guide was used to structure the interview. Table 1 summarises topic 
areas covered. Interviews lasted between 30 and 60 minutes.  All of the interviews were 
Final Author Approved Version: King, C, Grandison, T, Cawthorne, J, Currie, K  
Patient experience of hospital screening for carbapenemase-producing Enterobacteriaceae 
(CPE): a qualitative study 
6 
audio-recorded and transcribed verbatim.  Nine patients participated in the study, 5 women 
and 4 men.   One of the participants was between 20-30 years and the remaining 
participants were between 50 and 90 years.   
Data analysis 
Principles recommended by Braun & Clark (Braun and Clarke 2006) were used to undertake 
a thematic analysis of transcribed interviews.  Each transcript was read by two researchers 
(Authors 1 and 2) to generate preliminary concepts.  Following discussion between the 
researchers, a coding framework was developed to allow further exploration of patient 
experience of CPE screening and management, within and across participants.  NVivo© 10 
qualitative software was used to manage coded data. Rigour in analysis was ensured 
through two processes: coding and interpretation of data carried out by one researcher was 
independently reviewed by a second researcher; and, peer review of analysis and emerging 
findings at meetings by all three researchers.   
Findings  
Figure 1 provides an overview of the two main themes which were identified through the 
analysis of the data.   These will be explored in turn in the following section (I= Interviewer 
and R=Respondent in quotations):  
Theme 1: Difficulty understanding what CPE is: ‘I can’t really make sense of CPE’  
The first theme, ‘I can’t really make sense of CPE’, relates to the challenges patients 
experienced in trying to understand the consequences and complexities of receiving a 
positive swab result, indicating patient colonisation with CPE.  
Components of this theme were found to relate to the trajectory or pathway of the patient 
care experience from hospital admission to discharge and beyond, namely: agreeing to have 
a CPE screening test done; being informed of a positive CPE test result ‘on-the-move’ into 
isolation; communications with health care professionals about CPE; isolation and difficulty 
making sense of CPE management; and making sense of CPE post-discharge from hospital.  
These sub-categories of the theme will be explored in turn.  
 
Consent and CPE screening     
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While informal consent or permission to take a rectal swab would have been sought by the 
admitting nurse, the impression from patients was that this was a ‘standard procedure’ and 
not something they could or would normally refuse. Patients’ accounts suggested that the 
information which they received about CPE at the stage of initial screening was limited in its 
content and depth.  The short-hand explanation of CPE screening being to ‘check for bugs’ 
was commonly referred to by patients, to describe the purpose of CPE screening, as is 
illustrated in the quotation below:  
I didn’t even know what this [swab was for]… I knew it was to check for bugs and 
things but I didn’t know it was for something called CPE. (Patient 6) 
Many of the patients did report having a swab taken to be slightly uncomfortable and did 
talk about embarrassment, either their own or the nurse’s embarrassment.  However, for 
the most part, they did not feel that these emotions were problematic for themselves: 
Yeah, well originally they only did in your groin and up your nose … now, obviously 
they do the rectal one as well…. Well I didn’t have a problem with it.  (Patient 3)   
The routine nature of the swab as ‘the norm’, however, meant that the information patients 
gleaned about CPE tended to focus on the process of doing CPE screening rather than 
information which would allow them to better understand what CPE is and why screening 
takes place:  
I:   … when they [the nurse] came to do that screen what information did they provide 
you with? 
R:   They didn’t.  They just said it was the norm and it had to be done twice a week.   
(Patient 7)  
Patients’ accounts suggest that being screened for CPE was seen as a routine part of being in 
hospital by patients.  As such, patients’ knowledge of CPE colonisation and the purpose of 
screening for CPE when patients are admitted to hospital, however, appeared to be 
constrained by the procedure being seen as routine and an everyday part of a hospital 
admission.  
Learning about positive CPE test results   
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Many of the patients talked about a rapid process of movement from a main ward into 
isolation after a positive CPE test result for them had been received by ward staff.  Few, if 
any, of the patients spoke of being told the result of the screening test or having an 
opportunity to discuss the result by ward staff in a planned way.  In the main, patients 
described how information provided to them about the positive CPE test result took the 
form of ‘on-the-move’ practical information while being moved by nurses from a main ward 
to an isolation bay, often with the promise of more information from an infection 
prevention and control specialist at some point in the future:   
…they said they found out half an hour before I had this disease [CPE], whatever it is I 
had, and they said, we’ve got to move you into an isolation ward …I couldn’t 
understand why, because I was getting well and I was walking about, I thought they 
were going to send me home that particular week … (Patient 8)  
The act of moving patients into isolation meant that ‘everything had changed’ (Patient 6) 
leaving them with uncertainties about CPE and its implications for themselves and their 
families: 
It was a bit of a bombshell really because I’d got quite friendly with the people on the 
ward, we kind of encouraged each other, you know, and there was me taken from 
this environment where I felt fairly secure, into a single room.  Infection control didn’t 
come straight away so, I was kind of a bit…I don’t know what the word is…I think I 
felt a bit lost, you know; a bit like everything had changed.  (Patient 6)  
The description by Patient 6 of being told that she had had a positive CPE test result which 
required a move into isolation as a ‘bombshell’ goes some way to illustrating the gravitas of 
the experience of CPE management for patients. Again, lack of understanding of CPE and its 
implications at this stage of moving into isolation was evident in many of the patients’ 
accounts. 
 
Communications with health care professionals about CPE  
For all patients, interactions with health care professionals were identified as key to their 
efforts to make sense of CPE, albeit with varying levels of reported success.  All patients 
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talked about receiving information about CPE, however, this varied in relation to its content, 
depth, and patients’ interpretations of it.  Patients reported communicating with both ward 
staff and Infection Prevention and Control (IPC) staff about CPE.  Conversations with ward-
staff (doctors and nurses) were often referred to as cursory conversations from which they 
had gleaned a minimal amount of understanding about CPE:  
They never explained to me what it [CPE] was. It was something that they said 
everybody has, but occasionally somebody crops up with it and it’s more active. 
(Patient 5)  
Patients often felt that they needed to be proactive and opportunistic in their interactions 
with ward-staff to gain more information about CPE so that they could start to process what 
it was and what it meant for them and their care: 
…  It was more me being inquisitive than them trying to tell me.  (Patient 3)  
Patients mentioned communications with IPC staff as being promised and provided but not 
always meeting their information needs in terms of helping them to make sense of what 
CPE is and what it meant for them, despite the provision of oral and written information.  
The time lag between being informed of CPE status and speaking to an IPC nurse (around 
24-48 hours) was often problematic when patients felt in need of information more quickly. 
For some patients they felt that this engagement, when it did happen, had been relatively 
superficial and patients often felt that they could not ask the questions that they had:  
Well, somebody did come in the end to do with control, disease control or something, 
and discuss it, you know, and just said, well here’s the leaflet.  I think it was her that 
got the leaflet in the end, brought the leaflet and she just said what the bug was and, 
you know, and that was it really. (Patient 9)  
Patients also felt frustrated when they felt that ward-staff were devolving responsibility to 
meet their information needs about CPE to IPC staff: 
… it is a very busy ward and they often don’t have a lot of time to…and I think I did 
say things like, what is this CPE, and they said, oh we’re getting someone to come 
and talk to you about it.  So that’s not really a very good answer, is it? (Patient 6)  
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In the absence of other sources of information, patients talked about referring to the 
internet for information which they then tried, often in problematic ways, to make sense of 
in relation to their own situation and family: 
Right, I found it a bit of a shock when the nurse came and said you’ve got this CPE, I 
hadn’t a clue what it was about.  Never been in hospital since I was in my 20s, so it 
was quite an experience, and then me and another young woman that were in the 
same ward were isolated into two side wards.  There was no information given really 
and then a few days after someone found us a leaflet.  … But, the very first 
experience of it was the young woman was very computer literate, which I'm not, she 
went on to the computer and come across some article from...which newspaper?  It 
was the Guardian.  Oh, it was really alarming.   So, at that I started to worry 
immediately about my granddaughter who visited with the grandchild, and my 
granddaughter is pregnant and I have a low immune system, so I just lay awake all 
night worrying... (Patient 9)  
Patient knowledge about CPE, gleaned from their interactions and conversations with health 
care professionals, was often uncertain and conflicting for them to understand.  In the 
absence of explanation or discussion about what is currently known about CPE and how this 
can and is likely to develop and evolve, patients often felt left to try and make sense of what 
they were told:  
It’s just a basic thing really.  I mean, I know I’ve got this bug and I think...I think I’ve 
got it for life, I’m not sure.  To me I don’t know why they keep swabbing me if they 
know I’ve got it for life because they know I’ve got it, to be honest. … If it was one 
that disappeared in time that’s fair enough but I don’t know why I keep having to 
have this test now because they know I’ve got it anyway. (Patient 1)  
Despite staff efforts to provide both written and verbal information, patients’ accounts 
suggest that they often remained confused about CPE and found it difficult to make sense of 
what being colonised with CPE meant for their everyday lives.  
Being cared for in isolation  
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The experience of being in isolation rooms created additional uncertainties for patients, 
where again they often struggled to make sense of their situation by observing the 
behaviours of staff and the responses of other patients. Patients talked about how health 
care professionals would ‘put an apron on’ when they entered the room as an indication 
that they were taking precautionary measures.  On some occasions, however, health care 
professionals acted in ways that could isolate patients on more personal terms as this 
illustrative quotation where a patient refers to how a doctor chose not to shake her hand 
suggests:  
… one doctor came in one day and he didn't put them on [Personal Protective 
Equipment] he just said, I won't bother shaking hands with you because I’ll have to 
go and wash my hands.  (Patient 9)  
In addition to their observations of the actions of health care professionals, patients also 
reported on messages that they had found confusing such as being able to leave the 
isolation room as long as it was a for a short-time resulting in a lack of consistency in 
approach and confusion for patients about how CPE colonisation should be managed:   
Well, she did say to me, you know, you can go into the big ward and chat with people 
for short times, you know, but then when I did the nurses shooed me off and told me 
to go back to my room. So I was like…you know…and I did defend myself and I did say 
that I had been told that I can come in. … It’s quite confusing really; am I supposed to 
go or am I not. (Patient 6)  
Patients’ accounts suggest that fellow patients also found it difficult to know how to react 
to, and interact with, them.  Patient 6 (below) talks about her interactions with patients 
where she made efforts to reassure them that they would not ‘catch it’ [CPE] from her.  Her 
interaction with one patient who just wanted to ‘get rid of’ her, as she puts it, however, 
illustrates the potentially marginalising effects of CPE for patients in the absence of 
consistent information about CPE from health care professionals:  
I just said [when talking to fellow patients] I’ve got this hospital bug called CPE.  It 
doesn’t affect me; I’ve got no symptoms, but it can be passed on through touch and, 
you know, it’s not an air borne thing – so me talking to you here, you won’t catch it. I 
Final Author Approved Version: King, C, Grandison, T, Cawthorne, J, Currie, K  
Patient experience of hospital screening for carbapenemase-producing Enterobacteriaceae 
(CPE): a qualitative study 
12 
mean most people were fine about it … there was one lady and she was quite harsh 
really.  She said, oh well I’ve already got the runs, I don’t need anything else. And I 
said, well there aren’t any symptoms with this, it just lives in your gut. But I could tell 
she didn’t want to continue the conversation, she just wanted to go – get rid of me.  
(Patient 6)  
Overall, the patient experience during being cared for in an isolation room is indicative of 
uncertainty of the ‘rules’ of CPE management.  The unpredictability around the response of 
staff and other patients appeared to contribute to the challenge which patients experienced 
when trying to understand and make sense of CPE. 
Discharge from hospital 
Once patients had returned home they had an opportunity to reflect on their time in 
hospital and the impacts which CPE had had on their hospital experience and on them as 
individuals. Although most patients reported a sense of perspective about CPE, having had 
time to reflect on it since leaving hospital, it was clear from their accounts that the 
emotional impact and toll had been great.  Often patients would recount, in great detail, 
scenarios where they felt confused and conflicted about what was happening to them and 
the implications of it for them.  Once home, patients continued to mull over whether CPE 
was with them ‘for life’ or not as they made attempts to make coherent sense of CPE:  
I’ve been on the internet, and it’s mostly stuff comes from America, there is stuff 
coming from this country.  Like anything you take some of it with a pinch of salt, you 
don’t believe the internet.  But there’s some sides talk about an antibiotic, there’s 
other sides say there’s nothing, it’s just cleanliness.  (Patient 2)  
This same patient then went on to talk about a place of ‘resignation’ that he had come to in 
terms of having CPE, albeit, not a happy one:  
I’m resigned to it, but I would like to think that there is something round the corner … 
(Patient 2) 
As such, the lack of clarity experienced by most patients colonised with CPE while in hospital 
continued once they were discharged home and contributed to the difficulties they 
experienced in understanding and making sense of CPE. 
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Theme 2: CPE, blame and responsibility: ‘I feel as if they are saying it is my fault’ 
The second key theme which was identified in the data analysis was how patients’ 
experiences were shaped by feelings of blame and responsibility.  Patients’ accounts suggest 
that they experienced a tension related to CPE screening and its management, borne from 
the IPC measures implemented and necessary in order to control CPE transmission at an 
institutional level within the hospital, but which focused on them as individuals.  This 
tension resulted in patients experiencing emotional reactions related to feeling personal 
blame for being colonised with CPE. They also felt responsibility to control their bodies, 
through significant management of their hygiene, in order to prevent the transmission of 
CPE.  
Emotional responses to a positive CPE test result: contagion and feeling dirty   
The majority of patients described a complex emotional response to having a positive CPE 
test result and being moved into an isolation cubicle or ward. Emotional responses included 
concerns relating to contagion ‘I felt like I was contagious’, with one patient talking about 
‘feeling dirty’ and referring to feeling ‘like a leper’ (Patient 2):  
I can remember feeling dirty, I can remember feeling, oh my God, and when I told my 
wife she was quite upset.  In fact, she was so upset that when I got home, finally got 
home a few days later, she’d got a bucket with water and disinfectant in it and every 
time I took my underwear off it was going in there.  She doesn’t do it anymore, but 
that’s what she was doing at the time.  (Patient 2)  
Later in the interview, the same patient went on to sum up his feelings about CPE:  
If I had anything to say about CPE would be that I do feel sometimes like a leper.  I 
know they don’t treat me like a leper, but you can’t avoid feeling that way (Patient 2)  
These emotional responses existed for patients during their hospital admission when they 
were being cared for in isolation and continued after their discharge from hospital. These 
feelings of ‘being contagious’ yet that the circumstances that they found themselves in were 
not their ‘fault’ left patients in an emotional struggle as they tried to deal with feelings of 
blame.  The locus of this blame was non-specific as the quotation from Patient 1 illustrates, 
where she talks about the circumstance as not her own fault and also not being the nurses’ 
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fault.  The following example shows how patients struggled to make sense of their complex 
emotional responses in the absence of clear information about CPE (discussed in relation to 
Theme 1):    
But because of that I felt...I know it wasn’t my fault but I felt like I was contagious. … I 
did mention this to the nurse when she was taking me to this ward.  I said, ‘Well, I 
don’t feel...I know I’ve got to be kept separate but I feel as though I’m contagious’.  
Obviously it’s not her fault but that’s how I felt. (Patient 1)  
The use of terms such as ‘feeling contagious’ and ‘feeling dirty’ and ‘like a leper’ are 
powerful linguistic devices which illustrate the extent of patients’ emotional responses to a 
positive CPE test result and their subsequent care in isolation, emotions which can extend to 
the post-discharge period.  These feelings underpinned patients desire to disown blame and 
their feelings that they were being made responsible for something which was not their 
fault.  
Responsibility to keep yourself ‘perfectly clean’  
Individual responsibility to control their body through hygiene measures, for example, to 
‘make sure you wash your hands’ and 'keep perfectly clean'; and, a responsibility to protect 
their friends and family from CPE was a key theme within patients’ accounts:  
Well, it frightened me a little bit to think that, what can I do to stop it getting more 
active, and it was just like I’ve explained before, keep yourself perfectly clean at all 
times. (Patient 5)  
Many of the patients referred to infection control advice from health care professionals 
which focused on them as individuals and their hygiene practices as having the consequence 
of making them feel that having CPE was their fault (as discussed above) and that it was now 
their responsibility to manage it and to ensure that others did not come to harm as a result 
of their actions or negligence as described below:  
… they say you’ve got to be clean, blah, blah, blah, you’ve got to wash your hands 
every time you do this, you’ve got to wash your hands every time you do that, you’ve 
got to clean your below, and I do that as normal.  And I think to myself, well, they’re 
as good as saying it’s my fault and it’s not, you know what I mean, it’s not my fault, 
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it’s something I’ve caught in hospital.  But that’s what it feels like sometimes, that it’s 
my fault. (Patient 2)  
For some patients, the emotions connected with a positive CPE test result were quickly 
dissipated as they normalised the result using information they had received from health 
care professionals, for example, that it was not a problem unless they had diarrhoea.  
Within these accounts, however, the personal responsibility of patients to ensure that 
‘everybody around me would be quite safe’ and to ‘report back’ illustrates the extent to 
which CPE management became the responsibility of the individual to ensure close 
surveillance at all times and to protect their families:   
… when they first found out, there were two nurses came in, and there was the…the 
ones who do the special disease and infections, and they closed the little room door, 
because I was in a side ward, and they told me, and my son, they had to wear 
protective gloves and aprons, and they explained that nobody could catch the 
infection unless I caught a bad dose of diarrhoea, and if that didn’t happen at the 
hospital or at home, everybody around me would be quite safe, so there’s nothing to 
worry about of that concern. … And if I do have a bad dose of diarrhoea, then I must 
report it back to the hospital at once. (Patient 5) 
For the majority of the patients interviewed, the emotional consequences of a positive CPE 
test result were lasting for the duration of their hospital admission and after discharge and 
something for which they felt both blame and responsibility.   
Responsibility to prevent the transmission of CPE to family and friends    
Patients’ talked about the impact of a positive CPE test result for family and friends as one 
of their greatest concerns.  The impact for patients was very direct in relation to their 
relationships with their family with some patients self-excluding themselves from contact 
with family for fear of transmitting CPE.  For family and friends, the lack of knowledge about 
CPE meant that they had little ability to make a judgement on its implications for 
themselves.  A number of patients referred to MRSA, such as when Patient 1 (below) talks 
about ‘R-S’ (meaning MRSA).   Patients used MRSA as a well-known cultural touchpoint to a 
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well-publicised antimicrobial resistant organism which patients drew on when trying to 
understand CPE: 
...they’ve [family] not really said anything because I couldn’t tell them exactly what 
my infection was because I couldn’t remember what the woman said because 
obviously I was upset at the time ...and I think they’re not bothered unless it was the 
R-S...you know, that one. (Patient 1)  
Patient 5’s reference (below) to ‘a bug that was so dangerous at times’ and his wife’s 
response to CPE is an illustration of the fear that patients articulated about CPE and the 
responses of their family to it:  
… when it [CPE] was first explained, she [the patient’s wife] was completely shocked 
to think that I’d got a bug that was so dangerous at times, and they said at the time, 
no, everybody has one, and it’s just one in a thousand or one in a 100 that becomes 
active, and I’ve been one of the unlucky ones.  (Patient 5)  
Some patients talked about bracketing visitors into categories of vulnerable and non-
vulnerable people.  This process was often related to information that they had gleaned 
from the internet or conversations with health care professionals.  Patients had used this 
information to draw logic that CPE would cause few problems for the fit and healthy but 
could be problematic for those people who had an immune system which was in any way 
compromised or if for people who were elderly or young in age.  Patient 9 highlights that, 
with hindsight, she felt that this process of categorising her friends and family in this way 
and deciding who should visit was ‘a bit irrational’.  Within the hospital context and when 
finding it difficult to make sense of CPE, however, this was how she had acted in order to 
protect her friends and family from the possible transmission of CPE.  This role which 
patients took as guardians of their friends and family illustrates the extent to which patients 
felt they had been made responsible to prevent the transmission of CPE:   
I wouldn't allow her to come to the hospital, I was deprived like for a month of my 
granddaughter and great granddaughter. I was just too scared there was no 
way...and any other of my friends I was deprived of all them that has either just had 
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cancer...I would not let anyone near, the only people that come, there were lots of 
them, were my sons and their friends, so they were all strapping males. (Patient 9)  
As such, a sense of blame and responsibility were closely intertwined and played out in a 
number of ways in patients’ accounts, particularly in relation to their concern about the 
onward transmission of CPE to friends and family.   
Discussion 
To the authors’ knowledge, this is the first study to provide an in-depth account of the 
patient experience of being screened and managed in hospital for CPE colonisation. CPE is a 
relatively new AMRO, for which screening programmes have only recently been 
implemented within the UK (Public Health England 2014, Health Protection Scotland 2016).  
Thus, developing an understanding of the patient experience of being colonised with CPE 
will enable health care professionals to provide more sensitive care which responds to the 
needs expressed by colonised patients. 
A key challenge experienced by patients in this study was the difficulty in obtaining 
sufficient information about CPE to make sense of the implications of being colonised. The 
findings illustrate that from the request to screen, and onwards through the patient’s 
hospital admission, health care staff are perceived as having limited time to explain about 
CPE. For patients who screen positive for CPE, our findings suggest that staff often resort to 
short-cut language, for example, ‘you have a bug’, with explanations often given briefly 
alongside due IPC process, such as moving a patient into isolation. There appears to be a 
reliance of ward based staff on ‘specialist’ IPC staff providing information, however, patients 
may have to wait some days for this information, incurring uncertainty and anxiety in the 
process. This finding echoes that of a recent systematic review of patient experience of a 
range of other healthcare associated infections and colonisation (Authors, 2018), where 
included studies highlighted the frustration experienced by patients in trying to get 
information, from healthcare professionals, which met their needs. However, whereas our 
participants tended to perceive this as due to time pressures on staff, other studies have 
reported a perceived lack of staff knowledge about the healthcare associated infection 
(Criddle and Potter 2006, Lindberg, Carlsson et al. 2009, Skyman, Sjöström et al. 2010). The 
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findings of this study suggest that patients engage in an extensive process of reworking the 
information they have gained.  Their accounts suggest that they do this through a number of 
mechanisms: processing formal explanations about CPE given by health care professionals; 
accessing additional information from the internet; trying to make sense of CPE through 
how they have seen health care professionals and other patients act in relation to them in 
relation to either enacting IPC measures or resisting them; and, testing the boundaries of 
isolation imposed due to CPE.  It is through this fairly complex set of processes, this study 
suggests, that patients try to understand CPE and its implications for their own lives and the 
lives of their families.  
Patients’ emotional responses to CPE suggest that they experience it at a personal level 
where they feel both blame and responsibility for it. This personalisation results in 
emotional fall-out for patients in terms of how they feel about themselves (dirty), how they 
relate to their families (self-isolation), and the pressures of the increased policing of their 
bodies which the measures demand (must keep perfectly clean; if I have diarrhoea I must 
report it).  Fear over the risk of transmission can be debilitating for patients and is 
exacerbated by the assumption that transmission is both problematic and their 
responsibility to prevent.   Patient accounts suggest that they feel that that there is a 
requirement for them to police the boundaries of their own bodies and be ever-vigilant of 
their bodies, through hygiene measures, in ways that can be challenging in the everyday. 
Sociological literature on risk, explored by Lupton (1999), may help us to understand and 
bring meaning to these aspects of patients’ experiences.  Risk as a concept has been usefully 
operationalised within IPC clinical practice.  Rarely, however, is it considered or 
problematised in relation to its implications for patients and their experiences of health 
care.  The concept of risk is central to governance and how populations are monitored and 
controlled and how interventions are justified (Lupton 1999: 62).   With increasing 
awareness of AMR, populations have become the focus of hygiene and other measures to 
try and minimise the impacts of AMROs within populations.  The role of risk in governing 
populations and managing population health may go some way to explain why patients 
talked about feeling the need to be ‘perfectly clean’ and taking special measures to police 
their own bodies by refusing visits from family and friends who they deemed to be more 
vulnerable than others if they were to become ill or because they were already ill.  The role 
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of risk in shaping the health and illness experience of patients means that responsibility for 
what is a collective phenomenon caused by a complex inter-relationship of factors can be 
felt by individuals to be their responsibility.   In addition, many of the evidenced 
preventative IPC measures for HAIs are individual in nature, for example, hand-washing.  It 
should be noted that these IPC measures are well-evidenced as effective and have 
significant importance in terms of the delivery of safe, patient care (Storr, Twyman et al. 
2017). At the same time, however, the individualistic nature of these measures can act to 
make patients feel hyper-responsible individually to police the boundaries of their bodies 
rather than to view these measures as a collective response to a social phenomenon, such 
as AMR.   
In summary, the two major themes emerging from this study point to difficulties for  
patients in receiving and understanding information about CPE; and, a consequent sense of 
blame, responsibility, and uncertainty for patients. Findings from this study indicate the 
need for more effective strategies to provide accessible patient education, to ensure that 
patients are better informed and that their quality of life is not unduly or unnecessarily 
affected by CPE while in hospital or after discharge.   
Conclusion 
Given the public health challenge of AMR, screening to identify patients who may be 
colonised with resistant organisms such as CPE, is becoming an increasingly important 
aspect of nursing practice, in order to reduce risk of transmission of infection within 
hospitals.  Studies, such as this, which explore patient experience in depth provide the 
opportunity for research to inform clinical practice to ensure that patients’ information and 
support needs are addressed.  
Strengths and limitations 
Despite extensive efforts to recruit patients to the study, the sample size is small and, while 
rich and in-depth data was generated, we cannot be confident that data-saturation was 
achieved.    While acknowledging this limitation, however, the patients who did consent to 
take part in the study spoke at length about their experiences providing valuable insights 
into patient experience of CPE screening and management, which has relevance for the 
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design of not only CPE screening and management programmes but also AMRO 
programmes, more generally.  
Relevance to clinical practice 
The findings of this study are particularly relevant for the design of health care professional 
and patient education programmes relating to CPE.  These programmes require recognition 
of the ways in which patients make sense of CPE and how blame for CPE colonisation and 
responsibility to prevent its onward transmission are experienced by patients. However, it is 
also necessary to acknowledge that front-line staff must have opportunities to develop and 
maintain their knowledge of AMR in general and CPE in particular, in order to provide 
effective information and support to patients.  
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Figure 1: Thematic overview of findings  
 
 
Table 1: Summary of questions covered in interviews   
Introductory 
question  
In your own words, could you tell us about your experience of being screened for 
CPE while in hospital?  
Main questions 
about experience 
of CPE screening 
What information about CPE screening do you recall being provided with?   
How do you recall feeling about being screened for CPE colonisation?  How do 
•Consent and CPE screening  
•Learning about a positive CPE test result  
•Communicaiton with health care professionals about CPE  
•Being cared for in isolation  
•Discharge from hospital  
Difficulty 
understanding 
what CPE is: 'I 
can't make sense 
of CPE  
•Emotional responses to a postive CPE test result: 
contagion and feeling dirty  
•Responsibility to keep yourself 'perfectly clean'  
•Responsibility to prevent the transmission of CPE to 
family and friends  
 
CPE, blame and 
responsibility: 'I 
feel as if they are 
saying it is my 
fault'  
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and colonisation you feel about having been screened for CPE now? 
How did you feel about having the screening test for CPE (rectal swabbing)?   
How do you feel now?  
Can you tell us about being told about the results of the CPE screen?   
How did you/friends/family respond to the information provided by staff about 
CPE and its implications for your care?  
How did you feel about being treated in a single room (isolation from other 
patients)? 
Having been screened for CPE, what, in your view, are the advantages and 
disadvantages of CPE screening from your own perspective?  And for other 
hospital patients? The wider community?  
Questions about 
improving care  
Have you any suggestions about how CPE screening and the management of CPE 
within hospitals could be improved for patients?  
Concluding 
question  
Have you any other points you would like to talk about in relation to your 
experience of CPE screening and your care related to this?  
 
 
 
